Bumper Offer - Urjas oil Just @ Rs. 1 X
Vepan 250 Tablet DT, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Bacterial Infections, Tonsillitis, Throat Infection. Vepan 250 Tablet DT also has some secondary and off-label uses. These are listed below.
The optimal dosage of Vepan 250 Tablet DT is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
While these are the most often observed Vepan 250 Tablet DT side effects, there are can be others also. These have been listed below. Normally, these side effects of Vepan 250 Tablet DT are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Vepan 250 Tablet DT's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Vepan 250 Tablet DT's effects on the liver, heart and kidney are discussed below in the Vepan 250 Tablet DT related warnings section.
Other conditions have been mentioned below in the Vepan 250 Tablet DT contraindications section.
Drug reaction of Vepan 250 Tablet DT with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Vepan 250 Tablet DT, it is important to know that it is not safe while driving, and is not habit-forming.
Vepan 250 Tablet DT is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Vepan 250 Tablet DT is used -
Severe
Mild
Is the use of Vepan 250 Tablet DT safe for pregnant women?
Pregnant women can take Vepan safely.
Is the use of Vepan 250 Tablet DT safe during breastfeeding?
Vepan is completely safe for breastfeeding women.
What is the effect of Vepan 250 Tablet DT on the Kidneys?
Vepan rarely harms the kidneys.
What is the effect of Vepan 250 Tablet DT on the Liver?
Vepan is not harmful for the liver.
What is the effect of Vepan 250 Tablet DT on the Heart?
There are no any side effects of Vepan for the heart.
Vepan 250 Tablet DT should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Vepan 250 Tablet DT unless your doctor advises you to do so -
Is this Vepan 250 Tablet DT habit forming or addictive?
No, you will not get addicted to Vepan 250 Tablet DT.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Vepan 250 Tablet DT. So it is best to avoid driving.
Is it safe?
Yes, but take Vepan 250 Tablet DT only as per medical advice.
Is it able to treat mental disorders?
Vepan 250 Tablet DT is unable to treat or cure mental disorders.
Interaction between Food and Vepan 250 Tablet DT
You can take Vepan 250 Tablet DT with food.
Interaction between Alcohol and Vepan 250 Tablet DT
You may consume alcohol while taking Vepan 250 Tablet DT. But caution is still important.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)